StageZero Life Sciences Ltd. (SZLSF)

StageZero Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Feb 10, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	4	5	21	36	9	5
Market Cap Growth	-29.16%	-78.12%	-42.45%	312.71%	82.87%	-74.78%
Enterprise Value	5	6	20	37	12	8
Last Close Price	0.00	0.04	0.23	0.58	0.23	0.30
PS Ratio	1.26	1.19	4.06	8.61	62.43	25.48
PB Ratio	-0.40	-0.60	7.45	-28.97	-1.93	-0.86
EV/Sales Ratio	1.73	1.64	4.02	9.01	83.10	43.76
Debt / Equity Ratio	-0.15	-0.24	0.49	-2.89	-0.55	-0.52
Net Debt / Equity Ratio	-0.15	-0.24	-0.13	2.45	-0.53	-0.50
Net Debt / EBITDA Ratio	-0.30	-0.24	0.05	0.87	-0.51	-0.68
Net Debt / FCF Ratio	-1.65	-0.51	0.04	0.97	-0.51	-0.79
Asset Turnover	0.65	0.67	0.53	0.79	0.08	0.09
Inventory Turnover	21.86	16.65	10.19	15.61	11.07	11.11
Quick Ratio	0.01	0.01	0.39	1.22	0.06	0.03
Current Ratio	0.04	0.04	0.50	1.30	0.09	0.06
Return on Equity (ROE)	-	-	-979.39%	-	-	-
Return on Assets (ROA)	-63.79%	-85.34%	-51.97%	-44.60%	-181.32%	-140.91%
Return on Capital Employed (ROCE)	58.60%	122.50%	-134.90%	-126.60%	219.50%	114.70%
Earnings Yield	-344.52%	-253.61%	-36.39%	-19.21%	-40.21%	-77.98%
FCF Yield	-	-78.40%	-44.26%	-8.78%	-53.53%	-73.15%
Buyback Yield / Dilution	-32.99%	-40.60%	-57.77%	-69.14%	-54.89%	-41.63%

Updated Dec 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.